MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

August 06, 2015

In Uzbekistan’s Autonomous Republic of Karakalpakstan, Doctors Without Borders/Médecins Sans Frontières (MSF) runs a tuberculosis (TB) program in collaboration with the Ministry of Health, helping patients manage the side effects of their drug regimens and providing psychosocial support to improve treatment adherence. Here, MSF medical team leader Tetyana Pylypenko discusses MSF’s

December 17, 2013

Tuberculosis (TB) and its drug-resistant forms are a global health threat to which children are particularly vulnerable.

July 11, 2013

MSF doctor Emily Wise blogs from Karakalpakstan, Uzbekistan, where MSF is working to treat tuberculosis patients.

April 05, 2012

In northwestern Uzbekistan, drug-resistant forms of tuberculosis (TB) are spreading while only one in 10 people with TB receives treatment. Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 2,000 people with drug-resistant TB in Uzbekistan over the last 10 years.

March 18, 2012

Her coffin had already been built when Rohatay TagsAbdullaeva learned she could get help in her native Uzbekistan. As World TB Day approaches, MSF celebrates her good health, but also remembers the huge number of people with TB who cannot get the help they need.

January 11, 2012

Doctors Without Borders/Médecins Sans Frontières (MSF) is providing humanitarian aid to Haitian asylum seekers in Tabatinga, a town in the state of Amazonas, Brazil. 

October 04, 2011

Thousands of people with Chagas disease will go untreated in coming months due to a shortage of benznidazole, the first-line drug used in most endemic countries.

April 01, 2011

Michael O. Harhay, Piero L. Olliaro, Michel Vaillant, François Chappuis, María Angeles Lima, Koert Ritmeijer, Carlos Henrique Costa, Dorcas Lamounier Costa, Suman Rijal, Shyam Sundar, Manica Balasegaram
Am J Trop Med Hyg 2011;84(4):543-50.
American Journal of Tropical Medicine and Hygiene

Read more

Pages

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

August 06, 2015

In Uzbekistan’s Autonomous Republic of Karakalpakstan, Doctors Without Borders/Médecins Sans Frontières (MSF) runs a tuberculosis (TB) program in collaboration with the Ministry of Health, helping patients manage the side effects of their drug regimens and providing psychosocial support to improve treatment adherence. Here, MSF medical team leader Tetyana Pylypenko discusses MSF’s

December 17, 2013

Tuberculosis (TB) and its drug-resistant forms are a global health threat to which children are particularly vulnerable.

July 11, 2013

MSF doctor Emily Wise blogs from Karakalpakstan, Uzbekistan, where MSF is working to treat tuberculosis patients.

April 05, 2012

In northwestern Uzbekistan, drug-resistant forms of tuberculosis (TB) are spreading while only one in 10 people with TB receives treatment. Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 2,000 people with drug-resistant TB in Uzbekistan over the last 10 years.

March 18, 2012

Her coffin had already been built when Rohatay TagsAbdullaeva learned she could get help in her native Uzbekistan. As World TB Day approaches, MSF celebrates her good health, but also remembers the huge number of people with TB who cannot get the help they need.

January 11, 2012

Doctors Without Borders/Médecins Sans Frontières (MSF) is providing humanitarian aid to Haitian asylum seekers in Tabatinga, a town in the state of Amazonas, Brazil. 

October 04, 2011

Thousands of people with Chagas disease will go untreated in coming months due to a shortage of benznidazole, the first-line drug used in most endemic countries.

April 01, 2011

Michael O. Harhay, Piero L. Olliaro, Michel Vaillant, François Chappuis, María Angeles Lima, Koert Ritmeijer, Carlos Henrique Costa, Dorcas Lamounier Costa, Suman Rijal, Shyam Sundar, Manica Balasegaram
Am J Trop Med Hyg 2011;84(4):543-50.
American Journal of Tropical Medicine and Hygiene

Read more

Pages